[{"authors":null,"categories":null,"content":"I am a Serra H√∫nter Fellow (tenure-track lecturer) at the Department of Statistics and Operations Research of the Universitat Polit√®cnica de Catalunya - BarcelonaTech (UPC), and a member of the research group GRBIO. My research focuses on methods and software for clinical trials with multiple endpoints and adaptive platform trials.\n My [thesis dissertation](https://zenodo.org/record/4273986#.X7eu2WhKhPY) is available on Zenodo.-- Download my resum√© -- ","date":1607817600,"expirydate":-62135596800,"kind":"term","lang":"en","lastmod":1607817600,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"https://academic-demo.netlify.app/author/marta-bofill-roig/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/author/marta-bofill-roig/","section":"authors","summary":"I am a Serra H√∫nter Fellow (tenure-track lecturer) at the Department of Statistics and Operations Research of the Universitat Polit√®cnica de Catalunya - BarcelonaTech (UPC), and a member of the research group GRBIO.","tags":null,"title":"Marta Bofill Roig","type":"authors"},{"authors":null,"categories":null,"content":"   Table of Contents  What you will learn Program overview Courses in this program Meet your instructor    What you will learn  Fundamental Python programming skills Statistical concepts and how to apply them in practice Gain experience with the Scikit, including data visualization with Plotly and data wrangling with Pandas  Program overview The demand for skilled data science practitioners is rapidly growing. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi.\nCourses in this program  Python basics Build a foundation in Python.   Visualization Learn how to visualize data with Plotly.   Statistics Introduction to statistics for data science.   Meet your instructor Marta Bofill Roig Are there prerequisites? There are no prerequisites for the first course.\n How often do the courses run? Continuously, at your own pace.\n  Begin the course   --  ","date":1611446400,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1611446400,"objectID":"6c44676516c9bb741d8af2a46a67bfe6","permalink":"https://academic-demo.netlify.app/courses/ct/","publishdate":"2021-01-24T00:00:00Z","relpermalink":"/courses/ct/","section":"courses","summary":"Statistics for Clinical Trials","tags":null,"title":"üìä Learn Data Science","type":"book"},{"authors":null,"categories":null,"content":"   Table of Contents  What you will learn Program overview Courses in this program Meet your instructor FAQs    What you will learn  Fundamental Python programming skills Statistical concepts and how to apply them in practice Gain experience with the Scikit, including data visualization with Plotly and data wrangling with Pandas  Program overview The demand for skilled data science practitioners is rapidly growing. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi.\nCourses in this program  Python basics Build a foundation in Python.   Visualization Learn how to visualize data with Plotly.   Statistics Introduction to statistics for data science.   Meet your instructor Marta Bofill Roig FAQs Are there prerequisites? There are no prerequisites for the first course.\n How often do the courses run? Continuously, at your own pace.\n  Begin the course   ","date":1611446400,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1611446400,"objectID":"59c3ce8e202293146a8a934d37a4070b","permalink":"https://academic-demo.netlify.app/courses/example/","publishdate":"2021-01-24T00:00:00Z","relpermalink":"/courses/example/","section":"courses","summary":"An example of using Wowchemy's Book layout for publishing online courses.","tags":null,"title":"üìä Learn Data Science","type":"book"},{"authors":null,"categories":null,"content":"Build a foundation in Python.\n  1-2 hours per week, for 8 weeks\nLearn   Quiz What is the difference between lists and tuples? Lists\n Lists are mutable - they can be changed Slower than tuples Syntax: a_list = [1, 2.0, 'Hello world']  Tuples\n Tuples are immutable - they can\u0026rsquo;t be changed Tuples are faster than lists Syntax: a_tuple = (1, 2.0, 'Hello world')   Is Python case-sensitive? Yes\n","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"53c98a35af45c97a4fe2e86ef2f3e579","permalink":"https://academic-demo.netlify.app/courses/ct/python/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/ct/python/","section":"courses","summary":"Build a foundation in Python.\n","tags":null,"title":"Python basics","type":"book"},{"authors":null,"categories":null,"content":"Build a foundation in Python.\n  1-2 hours per week, for 8 weeks\nLearn   Quiz What is the difference between lists and tuples? Lists\n Lists are mutable - they can be changed Slower than tuples Syntax: a_list = [1, 2.0, 'Hello world']  Tuples\n Tuples are immutable - they can\u0026rsquo;t be changed Tuples are faster than lists Syntax: a_tuple = (1, 2.0, 'Hello world')   Is Python case-sensitive? Yes\n","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"17a31b92253d299002593b7491eedeea","permalink":"https://academic-demo.netlify.app/courses/example/python/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/example/python/","section":"courses","summary":"Build a foundation in Python.\n","tags":null,"title":"Python basics","type":"book"},{"authors":null,"categories":null,"content":"Learn how to visualize data with Plotly.\n  1-2 hours per week, for 8 weeks\nLearn   Quiz When is a heatmap useful? Lorem ipsum dolor sit amet, consectetur adipiscing elit.\n Write Plotly code to render a bar chart import plotly.express as px data_canada = px.data.gapminder().query(\u0026quot;country == 'Canada'\u0026quot;) fig = px.bar(data_canada, x='year', y='pop') fig.show()  ","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"49f8d942b3a22f4fed9cb1b472ae9aa4","permalink":"https://academic-demo.netlify.app/courses/ct/visualization/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/ct/visualization/","section":"courses","summary":"Learn how to visualize data with Plotly.\n","tags":null,"title":"Visualization","type":"book"},{"authors":null,"categories":null,"content":"Learn how to visualize data with Plotly.\n  1-2 hours per week, for 8 weeks\nLearn   Quiz When is a heatmap useful? Lorem ipsum dolor sit amet, consectetur adipiscing elit.\n Write Plotly code to render a bar chart import plotly.express as px data_canada = px.data.gapminder().query(\u0026quot;country == 'Canada'\u0026quot;) fig = px.bar(data_canada, x='year', y='pop') fig.show()  ","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"1b341b3479c8c6b1f807553b77e21b7c","permalink":"https://academic-demo.netlify.app/courses/example/visualization/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/example/visualization/","section":"courses","summary":"Learn how to visualize data with Plotly.\n","tags":null,"title":"Visualization","type":"book"},{"authors":null,"categories":null,"content":"Introduction to statistics for data science.\n  1-2 hours per week, for 8 weeks\nLearn The general form of the normal probability density function is:\n$$ f(x) = \\frac{1}{\\sigma \\sqrt{2\\pi} } e^{-\\frac{1}{2}\\left(\\frac{x-\\mu}{\\sigma}\\right)^2} $$\n The parameter $\\mu$ is the mean or expectation of the distribution. $\\sigma$ is its standard deviation. The variance of the distribution is $\\sigma^{2}$.   Quiz What is the parameter $\\mu$? The parameter $\\mu$ is the mean or expectation of the distribution.\n","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"e9ea2d450b89f5515bf093fd9badd966","permalink":"https://academic-demo.netlify.app/courses/ct/stats/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/ct/stats/","section":"courses","summary":"Introduction to statistics for data science.\n","tags":null,"title":"Statistics","type":"book"},{"authors":null,"categories":null,"content":"Introduction to statistics for data science.\n  1-2 hours per week, for 8 weeks\nLearn The general form of the normal probability density function is:\n$$ f(x) = \\frac{1}{\\sigma \\sqrt{2\\pi} } e^{-\\frac{1}{2}\\left(\\frac{x-\\mu}{\\sigma}\\right)^2} $$\n The parameter $\\mu$ is the mean or expectation of the distribution. $\\sigma$ is its standard deviation. The variance of the distribution is $\\sigma^{2}$.   Quiz What is the parameter $\\mu$? The parameter $\\mu$ is the mean or expectation of the distribution.\n","date":1609459200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1609459200,"objectID":"6f4078728d71b1b791d39f218bf2bdb1","permalink":"https://academic-demo.netlify.app/courses/example/stats/","publishdate":"2021-01-01T00:00:00Z","relpermalink":"/courses/example/stats/","section":"courses","summary":"Introduction to statistics for data science.\n","tags":null,"title":"Statistics","type":"book"},{"authors":[],"categories":null,"content":" Click on the Slides button above to view the built-in slides feature.   Slides can be added in a few ways:\n Create slides using Wowchemy\u0026rsquo;s Slides feature and link using slides parameter in the front matter of the talk file Upload an existing slide deck to static/ and link using url_slides parameter in the front matter of the talk file Embed your slides (e.g. Google Slides) or presentation video on this page using shortcodes.  Further event details, including page elements such as image galleries, can be added to the body of this page.\n","date":1906549200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1906549200,"objectID":"a8edef490afe42206247b6ac05657af0","permalink":"https://academic-demo.netlify.app/talk/example-talk/","publishdate":"2017-01-01T00:00:00Z","relpermalink":"/talk/example-talk/","section":"event","summary":"An example talk using Wowchemy's Markdown slides feature.","tags":[],"title":"Example Talk","type":"event"},{"authors":["Marta Bofill Roig","Pavla Krotka","Katharina Hees","Franz Koenig","Dominic Magirr","Peter Jacko","Tom Parke","Martin Posch"],"categories":null,"content":"Abstract: Shared controls in platform trials comprise concurrent and non-concurrent controls. For a given experimental arm, non-concurrent controls refer to data from patients allocated to the control arm before the arm enters the trial. The use of non-concurrent controls in the analysis is attractive because it may increase the trial\u0026rsquo;s power of testing treatment differences while decreasing the sample size. However, since arms are added sequentially in the trial, randomization occurs at different times, which can introduce bias in the estimates due to time trends. In this article, we present methods to incorporate non-concurrent control data in treatment-control comparisons, allowing for time trends. We focus mainly on frequentist approaches that model the time trend and Bayesian strategies that limit the borrowing level depending on the heterogeneity between concurrent and non-concurrent controls. We examine the impact of time trends, overlap between experimental treatment arms and entry times of arms in the trial on the operating characteristics of treatment effect estimators for each method under different patterns for the time trends. We argue under which conditions the methods lead to type 1 error control and discuss the gain in power compared to trials only using concurrent controls by means of a simulation study in which methods are compared.\n","date":1728000000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1728000000,"objectID":"8a4a9edd9c88af5b6731070f44069280","permalink":"https://academic-demo.netlify.app/publication/journal-article/bp_2025/","publishdate":"2024-10-04T00:00:00Z","relpermalink":"/publication/journal-article/bp_2025/","section":"publication","summary":"Abstract: Shared controls in platform trials comprise concurrent and non-concurrent controls. For a given experimental arm, non-concurrent controls refer to data from patients allocated to the control arm before the arm enters the trial.","tags":[],"title":"Treatment-control comparisons in platform trials including non-concurrent controls","type":"publication"},{"authors":["Lasse Fischer","Marta Bofill Roig","Werner Brannath"],"categories":null,"content":"Abstract: The closure principle is fundamental in multiple testing and has been used to derive many efficient procedures with familywise error rate control. However, it is often not suitable for modern research, as more flexible multiple testing settings are considered where not all hypotheses are known at the beginning of the evaluation. In this paper, we focus on online multiple testing where a possibly infinite sequence of hypotheses is tested over time. At each step, it must be decided on the current hypothesis without having any information about the hypotheses that have not been tested yet. Our main contribution is a new online closure principle which ensures that the resulting closed procedure can be applied in the online setting. We prove that any familywise error rate (FWER) controlling online procedure can be derived by this online closure principle. In addition, we demonstrate how short-cuts of these online closed procedures can be obtained under a suitable consonance property and apply the results in order to construct new online multiple testing methods. Finally, the new online closure principle is used to derive an improvement of the currently most promising online procedure with FWER control, the ADDIS-Spending under local dependence.\n","date":1711065600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1711065600,"objectID":"f8d0d24d41d4df5d2918358719bb88c3","permalink":"https://academic-demo.netlify.app/publication/journal-article/fbb_2022/","publishdate":"2024-03-22T00:00:00Z","relpermalink":"/publication/journal-article/fbb_2022/","section":"publication","summary":"Abstract: The closure principle is fundamental in multiple testing and has been used to derive many efficient procedures with familywise error rate control. However, it is often not suitable for modern research, as more flexible multiple testing settings are considered where not all hypotheses are known at the beginning of the evaluation.","tags":[],"title":"The Online Closure Principle","type":"publication"},{"authors":["Pavla Krotka","Martin Posch","Mohamed Gewily","G√ºnter H√∂glinger","Marta Bofill Roig"],"categories":null,"content":"","date":1709251200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1709251200,"objectID":"8bbead819d44eb495a57a8075180f4ea","permalink":"https://academic-demo.netlify.app/publication/journal-article/pk_2024/","publishdate":"2024-03-01T00:00:00Z","relpermalink":"/publication/journal-article/pk_2024/","section":"publication","summary":"Utilizing non-concurrent controls in the analysis of late-entering experimental arms in platform trials has recently received considerable attention, both on academic and regulatory levels. While incorporating this data can lead to increased power and lower required sample sizes, it might also introduce bias to the effect estimators if temporal drifts are present in the trial. Aiming to mitigate the potential calendar time bias, we propose various frequentist model-based approaches that leverage the non-concurrent control data, while adjusting for time trends. One of the currently available frequentist models incorporates time as a categorical fixed effect, separating the duration of the trial into periods, defined as time intervals bounded by any treatment arm entering or leaving the platform. In this work, we propose two extensions of this model. First, we consider an alternative definition of the time covariate by dividing the trial into fixed-length calendar time intervals. Second, we propose alternative methods to adjust for time trends. In particular, we investigate adjusting for autocorrelated random effects to account for dependency between closer time intervals and employing spline regression to model time with a smooth polynomial function. We evaluate the performance of the proposed approaches in a simulation study and illustrate their use by means of a case study.","tags":[],"title":"Statistical modeling to adjust for time trends in adaptive platform trials utilizing non-concurrent controls","type":"publication"},{"authors":["Lasse Fischer","Marta Bofill Roig","Werner Brannath"],"categories":null,"content":"Abstract: In this paper we consider online multiple testing with familywise error rate (FWER) control, where the probability of committing at least one type I error shall remain under control while testing a possibly infinite sequence of hypotheses over time. Currently, Adaptive-Discard (ADDIS) procedures seem to be the most promising online procedures with FWER control in terms of power. Now, our main contribution is a uniform improvement of the ADDIS principle and thus of all ADDIS procedures. This means, the methods we propose reject as least as much hypotheses as ADDIS procedures and in some cases even more, while maintaining FWER control. In addition, we show that our principle cannot be further uniformly improved. Finally, we apply the new principle to derive uniform improvements of the ADDIS-Spending and ADDIS-Graph.\n","date":1709078400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1709078400,"objectID":"38855c8454c7d34350167ae7cd126611","permalink":"https://academic-demo.netlify.app/publication/journal-article/fbb_2023b/","publishdate":"2024-02-28T00:00:00Z","relpermalink":"/publication/journal-article/fbb_2023b/","section":"publication","summary":"Abstract: In this paper we consider online multiple testing with familywise error rate (FWER) control, where the probability of committing at least one type I error shall remain under control while testing a possibly infinite sequence of hypotheses over time.","tags":[],"title":"An exhaustive ADDIS principle for online FWER control","type":"publication"},{"authors":["Marta Bofill Roig","Ekkehard Glimm","Tobias Mielke","Martin Posch"],"categories":null,"content":"","date":1704067200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1704067200,"objectID":"6b1707c3fd2c9b0f84460db43958cc04","permalink":"https://academic-demo.netlify.app/publication/journal-article/bgmp_2023/","publishdate":"2024-01-01T00:00:00Z","relpermalink":"/publication/journal-article/bgmp_2023/","section":"publication","summary":"Platform trials are randomized clinical trials that allow simultaneous comparison of multiple interventions, usually against a common control. Arms to test experimental interventions may enter and leave the platform over time. This implies that the number of experimental intervention arms in the trial may change over time. Determining optimal allocation rates to allocate patients to the treatment and control arms in platform trials is challenging because the change in treatment arms implies that also the optimal allocation rates will change when treatments enter or leave the platform. In addition, the optimal allocation depends on the analysis strategy used. In this paper, we derive optimal treatment allocation rates for platform trials with shared controls, assuming that a stratified estimation and testing procedure based on a regression model, is used to adjust for time trends. We consider both, analysis using concurrent controls only as well as analysis methods based on also non-concurrent controls and assume that the total sample size is fixed. The objective function to be minimized is the maximum of the variances of the effect estimators. We show that the optimal solution depends on the entry time of the arms in the trial and, in general, does not correspond to the square root of k allocation rule used in the classical multi-arm trials. We illustrate the optimal allocation and evaluate the power and type 1 error rate compared to trials using one-to-one and square root of k allocations by means of a case study.","tags":[],"title":"Optimal allocation strategies in platform trials with continuous endpoints","type":"publication"},{"authors":["Pavla Krotka","Katharina Hees","Peter Jacko","Dominic Magirr","Martin Posch","Marta Bofill Roig"],"categories":null,"content":"Abstract: Platform trials evaluate the efficacy of multiple treatments, allowing for late entry of the experimental arms and enabling efficiency gains by sharing controls. The power of individual treatment-control comparisons in such trials can be improved by utilizing non-concurrent controls in the analysis. We present the R-package NCC for the design and analysis of platform trials using non-concurrent controls. NCC allows for simulating platform trials and evaluating the properties of analysis methods that make use of non-concurrent controls in a variety of settings. We describe the main NCC functions and show how to use the package to simulate and analyse platform trials by means of specific examples.\n","date":1677628800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1677628800,"objectID":"2ad60cebc634a760f700523accd90681","permalink":"https://academic-demo.netlify.app/publication/journal-article/kb_2023/","publishdate":"2023-03-01T00:00:00Z","relpermalink":"/publication/journal-article/kb_2023/","section":"publication","summary":"Abstract: Platform trials evaluate the efficacy of multiple treatments, allowing for late entry of the experimental arms and enabling efficiency gains by sharing controls. The power of individual treatment-control comparisons in such trials can be improved by utilizing non-concurrent controls in the analysis.","tags":[],"title":"NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls","type":"publication"},{"authors":["Lasse Fischer","Marta Bofill Roig","Werner Brannath"],"categories":null,"content":"Abstract: In recent years, graphical multiple testing procedures have gained popularity due to their generality and ease of interpretation. In contemporary research, online error control is often required, where an error criterion, such as familywise error rate (FWER) or false discovery rate (FDR), shall remain under control while testing an a priori unbounded sequence of hypotheses. Although the classical graphical procedure can be extended to the online setting, previous work has shown that it leads to low power, and other approaches, such as Adaptive-Discard (ADDIS) procedures, are preferred instead. In this paper, we introduce an ADDIS-Graph with FWER control and its extension for the FDR setting. These graphical ADDIS procedures combine the good interpretability of graphical procedures with the high online power of ADDIS procedures. Moreover, they can be adapted to a local dependence structure and an asynchronous testing setup, leading to power improvements over the current state-of-art methods. Consequently, the proposed methods are useful for a wide range of applications, including innovative complex trial designs, such as platform trials, and large-scale test designs, such as in the evaluation of A/B tests for marketing research.\n","date":1672531200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672531200,"objectID":"09aa70010d06c8827c3fe2b3cb7632b9","permalink":"https://academic-demo.netlify.app/publication/journal-article/fbb_2023/","publishdate":"2023-01-01T00:00:00Z","relpermalink":"/publication/journal-article/fbb_2023/","section":"publication","summary":"Abstract: In recent years, graphical multiple testing procedures have gained popularity due to their generality and ease of interpretation. In contemporary research, online error control is often required, where an error criterion, such as familywise error rate (FWER) or false discovery rate (FDR), shall remain under control while testing an a priori unbounded sequence of hypotheses.","tags":[],"title":"An Adaptive Discard Graph for online error control","type":"publication"},{"authors":["Marta Bofill Roig","Cora Burgwinkel","Ursula Garczarek","Franz Koenig","Martin Posch","Quynh Nguyen","Katharina Hees"],"categories":null,"content":"Abstract: Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared control group in platform trials increases the trial efficiency compared to separate trials. Because of the later entry of some of the experimental treatment arms, the shared control group includes concurrent and non-concurrent control data. For a given experimental arm, non-concurrent controls refer to patients allocated to the control arm before the arm enters the trial, while concurrent controls refer to control patients that are randomised concurrently to the experimental arm. Using non-concurrent controls can result in bias in the estimate in case of time trends if the appropriate methodology is not used and the assumptions are not met. In this paper, we faced two main objectives. In the first, we aimed to identify the methods currently available for incorporating non-concurrent controls, clarify the key concepts and assumptions, and name the main characteristics of each method. For this purpose, we systematically searched research articles on methods to include non-concurrent controls. The second objective is to summarise the current regulatory view on non-concurrent controls to clarify the key concepts and current guidance. Therefore, we conducted a systematic search in regulatory guidelines regarding using non-concurrent controls and summarised the most relevant arguments and recommended methods. Finally, we discuss the advantages and potential caveats of using non-concurrent controls.\n","date":1668643200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1668643200,"objectID":"bf861ce1d276fb40fcbc29d0a0eb78f5","permalink":"https://academic-demo.netlify.app/publication/journal-article/bh_2022/","publishdate":"2022-11-17T00:00:00Z","relpermalink":"/publication/journal-article/bh_2022/","section":"publication","summary":"Abstract: Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared control group in platform trials increases the trial efficiency compared to separate trials.","tags":[],"title":"On the use of non-concurrent controls in platform trials: A scoping review","type":"publication"},{"authors":["Marta Bofill Roig","Guadalupe G√≥mez Melis","Martin Posch","Franz Koenig"],"categories":null,"content":"Abstract: For randomized clinical trials where a single, primary, binary endpoint would require unfeasibly large sample sizes, composite endpoints are widely chosen as the primary endpoint. Despite being commonly used, composite endpoints entail challenges in designing and interpreting results. Given that the components may be of different relevance and have different effect sizes, the choice of components must be made carefully. Especially, sample size calculations for composite binary endpoints depend not only on the anticipated effect sizes and event probabilities of the composite components, but also on the correlation between them. However, information on the correlation between endpoints is usually not reported in the literature which can be an obstacle for planning of future sound trial design. We consider two-arm randomized controlled trials with a primary composite binary endpoint and an endpoint that consists only of the clinically more important component of the composite endpoint. We propose a trial design that allows an adaptive modification of the primary endpoint based on blinded information obtained at an interim analysis. Especially, we consider a decision rule to select between a composite endpoint and its most relevant component as primary endpoint. The decision rule chooses the endpoint with the lower estimated required sample size. Additionally, the sample size is reassessed using the estimated event probabilities and correlation, and the expected effect sizes of the composite components. We investigate the statistical power and significance level under the proposed design through simulations. We show that the adaptive design is equally or more powerful than designs without adaptive modification on the primary endpoint. Besides, the targeted power is achieved even if the correlation is misspecified at the planning stage while maintaining the type 1 error. All the computations are implemented in R and illustrated by means of a peritoneal dialysis trial.\n","date":1662249600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1662249600,"objectID":"23eff3dd31988b48113e393c7fe2a5f0","permalink":"https://academic-demo.netlify.app/publication/journal-article/bgpk_2022/","publishdate":"2022-09-04T00:00:00Z","relpermalink":"/publication/journal-article/bgpk_2022/","section":"publication","summary":"Abstract: For randomized clinical trials where a single, primary, binary endpoint would require unfeasibly large sample sizes, composite endpoints are widely chosen as the primary endpoint. Despite being commonly used, composite endpoints entail challenges in designing and interpreting results.","tags":[],"title":"Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment","type":"publication"},{"authors":["Jordi Cortes-Martinez","Marta Bofill Roig","Guadalupe G√≥mez Melis"],"categories":null,"content":"Abstract Composite endpoints are widely used as primary endpoints in clinical trials. Designing trials with time-to-event endpoints can be particularly challenging because the proportional hazard assumption usually does not hold when using a composite endpoint, even when the premise remains true for their components. Consequently, the conventional formulae for sample size calculation do not longer apply. We present the R package CompAREdesign by means of which the key elements of trial designs, such as the sample size and effect sizes, can be computed based on the information on the composite endpoint components. CompAREdesign provides the functions to assess the sensitivity and robustness of design calculations to variations in initial values and assumptions. Furthermore, we describe other features of the package, such as functions for the design of trials with binary composite endpoints, and functions to simulate trials with composite endpoints under a wide range of scenarios.\n","date":1660089600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1660089600,"objectID":"763cc1396f5fd0de5eae487b2c1aaa67","permalink":"https://academic-demo.netlify.app/publication/journal-article/cbg_2022/","publishdate":"2022-08-10T00:00:00Z","relpermalink":"/publication/journal-article/cbg_2022/","section":"publication","summary":"Abstract Composite endpoints are widely used as primary endpoints in clinical trials. Designing trials with time-to-event endpoints can be particularly challenging because the proportional hazard assumption usually does not hold when using a composite endpoint, even when the premise remains true for their components.","tags":[],"title":"Design of Trials with Composite Endpoints with the R Package CompAREdesign","type":"publication"},{"authors":["Marta Bofill Roig","Pavla Krotka","Carl-Fredrik Burman","Ekkehard Glimm","Katharina Hees","Peter Jacko","Franz Koenig","Dominic Magirr","Peter Mesenbrink","Kert Viele","Martin Posch"],"categories":null,"content":"Abstract: Platform trials can evaluate the efficacy of several treatments compared to a control. The number of treatments is not fixed, as arms may be added or removed as the trial progresses. Platform trials are more efficient than independent parallel-group trials because of using shared control groups. For arms entering the trial later, not all patients in the control group are randomised concurrently. The control group is then divided into concurrent and non-concurrent controls. Using non-concurrent controls (NCC) can improve the trial\u0026rsquo;s efficiency, but can introduce bias due to time trends. We focus on a platform trial with two treatment arms and a common control arm. Assuming that the second treatment arm is added later, we assess the robustness of model-based approaches to adjust for time trends when using NCC. We consider approaches where time trends are modeled as linear or as a step function, with steps at times where arms enter or leave the trial. For trials with continuous or binary outcomes, we investigate the type 1 error (t1e) rate and power of testing the efficacy of the newly added arm under a range of scenarios. In addition to scenarios where time trends are equal across arms, we investigate settings with trends that are different or not additive in the model scale. A step function model fitted on data from all arms gives increased power while controlling the t1e, as long as the time trends are equal for the different arms and additive on the model scale. This holds even if the trend\u0026rsquo;s shape deviates from a step function if block randomisation is used. But if trends differ between arms or are not additive on the model scale, t1e control may be lost. The efficiency gained by using step function models to incorporate NCC can outweigh potential biases. However, the specifics of the trial, plausibility of different time trends, and robustness of results should be considered.\n","date":1659571200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1659571200,"objectID":"a8d335eded258e7456d0caa28d46db85","permalink":"https://academic-demo.netlify.app/publication/journal-article/bp_2021/","publishdate":"2022-08-04T00:00:00Z","relpermalink":"/publication/journal-article/bp_2021/","section":"publication","summary":"Abstract: Platform trials can evaluate the efficacy of several treatments compared to a control. The number of treatments is not fixed, as arms may be added or removed as the trial progresses.","tags":[],"title":"On model-based time trend adjustments in platform trials with non-concurrent controls","type":"publication"},{"authors":["Marta Bofill Roig","Franz Koenig","Elias Meyer","Martin Posch"],"categories":null,"content":"","date":1654300800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1654300800,"objectID":"0fde982b6a253640358439729fcbdb81","permalink":"https://academic-demo.netlify.app/publication/journal-article/bkmp_2022/","publishdate":"2022-06-04T00:00:00Z","relpermalink":"/publication/journal-article/bkmp_2022/","section":"publication","summary":"","tags":[],"title":"Commentary: Two approaches to analyze platform trials incorporating non-concurrent controls with a common assumption","type":"publication"},{"authors":["Marta Bofill Roig","Guadalupe G√≥mez Melis"],"categories":null,"content":"Abstract: We propose a class of two-sample statistics for testing the equality of proportions and the equality of survival functions. We build our proposal on a weighted combination of a score test for the difference in proportions and a Weighted Kaplan-Meier statistic-based test for the difference of survival functions. The proposed statistics are fully non-parametric and do not rely on the proportional hazards assumption for the survival outcome. We present the asymptotic distribution of these statistics, propose a variance estimator and show their asymptotic properties under fixed and local alternatives. We discuss different choices of weights including those that control the relative relevance of each outcome and emphasize the type of difference to be detected in the survival outcome. We evaluate the performance of these statistics with a simulation study, and illustrate their use with a randomized phase III cancer vaccine trial. We have implemented the proposed statistics in the R package SurvBin, available on GitHub (https://github.com/MartaBofillRoig/SurvBin).\n","date":1630713600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1630713600,"objectID":"22dbbe54a6e34684f2ae912bd959c6de","permalink":"https://academic-demo.netlify.app/publication/journal-article/bg_2020/","publishdate":"2021-09-04T00:00:00Z","relpermalink":"/publication/journal-article/bg_2020/","section":"publication","summary":"Abstract: We propose a class of two-sample statistics for testing the equality of proportions and the equality of survival functions. We build our proposal on a weighted combination of a score test for the difference in proportions and a Weighted Kaplan-Meier statistic-based test for the difference of survival functions.","tags":[],"title":"A class of two-sample nonparametric statistics for binary and time-to-event outcomes","type":"publication"},{"authors":["Marta Bofill Roig","Âê≥ÊÅ©ÈÅî"],"categories":["Demo","ÊïôÁ®ã"],"content":"Overview  The Wowchemy website builder for Hugo, along with its starter templates, is designed for professional creators, educators, and teams/organizations - although it can be used to create any kind of site The template can be modified and customised to suit your needs. It\u0026rsquo;s a good platform for anyone looking to take control of their data and online identity whilst having the convenience to start off with a no-code solution (write in Markdown and customize with YAML parameters) and having flexibility to later add even deeper personalization with HTML and CSS You can work with all your favourite tools and apps with hundreds of plugins and integrations to speed up your workflows, interact with your readers, and much more  Get Started  üëâ Create a new site üìö Personalize your site üí¨ Chat with the Wowchemy community or Hugo community üê¶ Twitter: @wowchemy @GeorgeCushen #MadeWithWowchemy üí° Request a feature or report a bug for Wowchemy ‚¨ÜÔ∏è Updating Wowchemy? View the Update Guide and Release Notes  Crowd-funded open-source software To help us develop this template and software sustainably under the MIT license, we ask all individuals and businesses that use it to help support its ongoing maintenance and development via sponsorship.\n‚ù§Ô∏è Click here to become a sponsor and help support Wowchemy\u0026rsquo;s future ‚ù§Ô∏è As a token of appreciation for sponsoring, you can unlock these awesome rewards and extra features ü¶Ñ‚ú®\nEcosystem  Hugo Academic CLI: Automatically import publications from BibTeX  Inspiration Check out the latest demo of what you\u0026rsquo;ll get in less than 10 minutes, or view the showcase of personal, project, and business sites.\nFeatures  Page builder - Create anything with widgets and elements Edit any type of content - Blog posts, publications, talks, slides, projects, and more! Create content in Markdown, Jupyter, or RStudio Plugin System - Fully customizable color and font themes Display Code and Math - Code highlighting and LaTeX math supported Integrations - Google Analytics, Disqus commenting, Maps, Contact Forms, and more! Beautiful Site - Simple and refreshing one page design Industry-Leading SEO - Help get your website found on search engines and social media Media Galleries - Display your images and videos with captions in a customizable gallery Mobile Friendly - Look amazing on every screen with a mobile friendly version of your site Multi-language - 34+ language packs including English, ‰∏≠Êñá, and Portugu√™s Multi-user - Each author gets their own profile page Privacy Pack - Assists with GDPR Stand Out - Bring your site to life with animation, parallax backgrounds, and scroll effects One-Click Deployment - No servers. No databases. Only files.  Themes Wowchemy and its templates come with automatic day (light) and night (dark) mode built-in. Alternatively, visitors can choose their preferred mode - click the moon icon in the top right of the Demo to see it in action! Day/night mode can also be disabled by the site admin in params.toml.\nChoose a stunning theme and font for your site. Themes are fully customizable.\nLicense Copyright 2016-present George Cushen.\nReleased under the MIT license.\n","date":1607817600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1607817600,"objectID":"279b9966ca9cf3121ce924dca452bb1c","permalink":"https://academic-demo.netlify.app/post/getting-started/","publishdate":"2020-12-13T00:00:00Z","relpermalink":"/post/getting-started/","section":"post","summary":"Welcome üëã We know that first impressions are important, so we've populated your new site with some initial content to help you get familiar with everything in no time.","tags":["Academic","ÂºÄÊ∫ê"],"title":"Welcome to Wowchemy, the website builder for Hugo","type":"post"},{"authors":null,"categories":["R"],"content":"\rR Markdown\rThis is an R Markdown document. Markdown is a simple formatting syntax for authoring HTML, PDF, and MS Word documents. For more details on using R Markdown see http://rmarkdown.rstudio.com.\nYou can embed an R code chunk like this:\nsummary(cars)\r## speed dist ## Min. : 4.0 Min. : 2.00 ## 1st Qu.:12.0 1st Qu.: 26.00 ## Median :15.0 Median : 36.00 ## Mean :15.4 Mean : 42.98 ## 3rd Qu.:19.0 3rd Qu.: 56.00 ## Max. :25.0 Max. :120.00\rfit \u0026lt;- lm(dist ~ speed, data = cars)\rfit\r## ## Call:\r## lm(formula = dist ~ speed, data = cars)\r## ## Coefficients:\r## (Intercept) speed ## -17.579 3.932\r\rIncluding Plots\rYou can also embed plots. See Figure 1 for example:\npar(mar = c(0, 1, 0, 1))\rpie(\rc(280, 60, 20),\rc(\u0026#39;Sky\u0026#39;, \u0026#39;Sunny side of pyramid\u0026#39;, \u0026#39;Shady side of pyramid\u0026#39;),\rcol = c(\u0026#39;#0292D8\u0026#39;, \u0026#39;#F7EA39\u0026#39;, \u0026#39;#C4B632\u0026#39;),\rinit.angle = -50, border = NA\r)\r\rFigure 1: A fancy pie chart.\r\r\r","date":1606875194,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1606875194,"objectID":"bf1eb249db79f10ace7d22321494165a","permalink":"https://academic-demo.netlify.app/post/2020-12-01-r-rmarkdown/","publishdate":"2020-12-01T21:13:14-05:00","relpermalink":"/post/2020-12-01-r-rmarkdown/","section":"post","summary":"R Markdown\rThis is an R Markdown document. Markdown is a simple formatting syntax for authoring HTML, PDF, and MS Word documents. For more details on using R Markdown see http://rmarkdown.","tags":["R Markdown","plot","regression"],"title":"Hello R Markdown","type":"post"},{"authors":["Marta Bofill Roig","Yu Shen","Guadalupe G√≥mez Melis"],"categories":null,"content":"Abstract: Pathologic complete response (pCR) is a common primary endpoint for a phase II trial or even accelerated approval of neoadjuvant cancer therapy. If granted, a two-arm confirmatory trial is often required to demonstrate the efficacy with a time-to-event outcome such as overall survival. However, the design of a subsequent phase III trial based on prior information on the pCR effect is not straightforward. Aiming at designing such phase III trials with overall survival as primary endpoint using pCR information from previous trials, we consider a mixture model that incorporates both the survival and the binary endpoints. We propose to base the comparison between arms on the difference of the restricted mean survival times, and show how the effect size and sample size for overall survival rely on the probability of the binary response and the survival distribution by response status, both for each treatment arm. Moreover, we provide the sample size calculation under different scenarios and accompany them with an R package where all the computations have been implemented. We evaluate our proposal with a simulation study, and illustrate its application through a neoadjuvant breast cancer trial.\n","date":1598659200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1598659200,"objectID":"23cddcfa8e8f84b57338c73c1d847b6f","permalink":"https://academic-demo.netlify.app/publication/journal-article/bsg_2020/","publishdate":"2020-08-29T00:00:00Z","relpermalink":"/publication/journal-article/bsg_2020/","section":"publication","summary":"Abstract: Pathologic complete response (pCR) is a common primary endpoint for a phase II trial or even accelerated approval of neoadjuvant cancer therapy. If granted, a two-arm confirmatory trial is often required to demonstrate the efficacy with a time-to-event outcome such as overall survival.","tags":[],"title":"Design of phase III trials with long-term survival outcomes based on short-term binary results","type":"publication"},{"authors":["Marta Bofill Roig","Jordi Cortes-Martinez","Guadalupe G√≥mez Melis"],"categories":null,"content":"Summary points:\n This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components. We highlight the very important role of the association between components in choosing the most efficient endpoint to use as primary. For better grounded future trials, we recommend trialists to always reporting the association between components of the composite endpoint. Common fallacies to note when using composite endpoints: i) composite endpoints always imply higher power; ii) treatment effect on the composite endpoint is similar to the average effects of its components; and iii) the probability of observing the primary endpoint increases significantly.  ","date":1578614400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1578614400,"objectID":"3dd0ea3c8cedaacc9c3e1b7762577cfe","permalink":"https://academic-demo.netlify.app/publication/journal-article/bcg_2020/","publishdate":"2020-01-10T00:00:00Z","relpermalink":"/publication/journal-article/bcg_2020/","section":"publication","summary":"Summary points:\n This article considers the combination of two binary or two time-to-event endpoints to form the primary composite endpoint for leading a trial. It discusses the relative efficiency of choosing a composite endpoint over one of its components in terms of: the frequencies of observing each component; the relative treatment effect of the tested therapy; and the association between both components.","tags":[],"title":"Decision tool and Sample Size Calculator for Composite Endpoints","type":"publication"},{"authors":null,"categories":null,"content":"Academic is designed to give technical content creators a seamless experience. You can focus on the content and Academic handles the rest.\nHighlight your code snippets, take notes on math classes, and draw diagrams from textual representation.\nOn this page, you\u0026rsquo;ll find some examples of the types of technical content that can be rendered with Academic.\nExamples Code Academic supports a Markdown extension for highlighting code syntax. You can enable this feature by toggling the highlight option in your config/_default/params.toml file.\n```python import pandas as pd data = pd.read_csv(\u0026quot;data.csv\u0026quot;) data.head() ```  renders as\nimport pandas as pd data = pd.read_csv(\u0026quot;data.csv\u0026quot;) data.head()  Charts Academic supports the popular Plotly chart format.\nSave your Plotly JSON in your page folder, for example chart.json, and then add the {{\u0026lt; chart data=\u0026quot;chart\u0026quot; \u0026gt;}} shortcode where you would like the chart to appear.\nDemo:\n  (function() { let a = setInterval( function() { if ( typeof window.Plotly === 'undefined' ) { return; } clearInterval( a ); Plotly.d3.json(\"./line-chart.json\", function(chart) { Plotly.plot('chart-479836251', chart.data, chart.layout, {responsive: true}); }); }, 500 ); })();  You might also find the Plotly JSON Editor useful.\nMath Academic supports a Markdown extension for $\\LaTeX$ math. You can enable this feature by toggling the math option in your config/_default/params.toml file.\nTo render inline or block math, wrap your LaTeX math with $...$ or $$...$$, respectively.\nExample math block:\n$$\\gamma_{n} = \\frac{ \\left | \\left (\\mathbf x_{n} - \\mathbf x_{n-1} \\right )^T \\left [\\nabla F (\\mathbf x_{n}) - \\nabla F (\\mathbf x_{n-1}) \\right ] \\right |} {\\left \\|\\nabla F(\\mathbf{x}_{n}) - \\nabla F(\\mathbf{x}_{n-1}) \\right \\|^2}$$  renders as\n$$\\gamma_{n} = \\frac{ \\left | \\left (\\mathbf x_{n} - \\mathbf x_{n-1} \\right )^T \\left [\\nabla F (\\mathbf x_{n}) - \\nabla F (\\mathbf x_{n-1}) \\right ] \\right |}{\\left |\\nabla F(\\mathbf{x}_{n}) - \\nabla F(\\mathbf{x}_{n-1}) \\right |^2}$$\nExample inline math $\\nabla F(\\mathbf{x}_{n})$ renders as $\\nabla F(\\mathbf{x}_{n})$.\nExample multi-line math using the \\\\\\\\ math linebreak:\n$$f(k;p_{0}^{*}) = \\begin{cases}p_{0}^{*} \u0026amp; \\text{if }k=1, \\\\\\\\ 1-p_{0}^{*} \u0026amp; \\text{if }k=0.\\end{cases}$$  renders as\n$$f(k;p_{0}^{*}) = \\begin{cases}p_{0}^{*} \u0026amp; \\text{if }k=1, \\\\\n1-p_{0}^{*} \u0026amp; \\text{if }k=0.\\end{cases}$$\nDiagrams Academic supports a Markdown extension for diagrams. You can enable this feature by toggling the diagram option in your config/_default/params.toml file or by adding diagram: true to your page front matter.\nAn example flowchart:\n```mermaid graph TD A[Hard] --\u0026gt;|Text| B(Round) B --\u0026gt; C{Decision} C --\u0026gt;|One| D[Result 1] C --\u0026gt;|Two| E[Result 2] ```  renders as\ngraph TD A[Hard] --\u0026gt;|Text| B(Round) B --\u0026gt; C{Decision} C --\u0026gt;|One| D[Result 1] C --\u0026gt;|Two| E[Result 2]  An example sequence diagram:\n```mermaid sequenceDiagram Alice-\u0026gt;\u0026gt;John: Hello John, how are you? loop Healthcheck John-\u0026gt;\u0026gt;John: Fight against hypochondria end Note right of John: Rational thoughts! John--\u0026gt;\u0026gt;Alice: Great! John-\u0026gt;\u0026gt;Bob: How about you? Bob--\u0026gt;\u0026gt;John: Jolly good! ```  renders as\nsequenceDiagram Alice-\u0026gt;\u0026gt;John: Hello John, how are you? loop Healthcheck John-\u0026gt;\u0026gt;John: Fight against hypochondria end Note right of John: Rational thoughts! John--\u0026gt;\u0026gt;Alice: Great! John-\u0026gt;\u0026gt;Bob: How about you? Bob--\u0026gt;\u0026gt;John: Jolly good!  An example Gantt diagram:\n```mermaid gantt section Section Completed :done, des1, 2014-01-06,2014-01-08 Active :active, des2, 2014-01-07, 3d Parallel 1 : des3, after des1, 1d Parallel 2 : des4, after des1, 1d Parallel 3 : des5, after des3, 1d Parallel 4 : des6, after des4, 1d ```  renders as\ngantt section Section Completed :done, des1, 2014-01-06,2014-01-08 Active :active, des2, 2014-01-07, 3d Parallel 1 : des3, after des1, 1d Parallel 2 : des4, after des1, 1d Parallel 3 : des5, after des3, 1d Parallel 4 : des6, after des4, 1d  An example class diagram:\n```mermaid classDiagram Class01 \u0026lt;|-- AveryLongClass : Cool \u0026lt;\u0026lt;interface\u0026gt;\u0026gt; Class01 Class09 --\u0026gt; C2 : Where am i? Class09 --* C3 Class09 --|\u0026gt; Class07 Class07 : equals() Class07 : Object[] elementData Class01 : size() Class01 : int chimp Class01 : int gorilla class Class10 { \u0026lt;\u0026lt;service\u0026gt;\u0026gt; int id size() } ```  renders as\nclassDiagram Class01 \u0026lt;|-- AveryLongClass : Cool \u0026lt;\u0026lt;interface\u0026gt;\u0026gt; Class01 Class09 --\u0026gt; C2 : Where am i? Class09 --* C3 Class09 --|\u0026gt; Class07 Class07 : equals() Class07 : Object[] elementData Class01 : size() Class01 : int chimp Class01 : int gorilla class Class10 { \u0026lt;\u0026lt;service\u0026gt;\u0026gt; int id size() }  An example state diagram:\n```mermaid stateDiagram [*] --\u0026gt; Still Still --\u0026gt; [*] Still --\u0026gt; Moving Moving --\u0026gt; Still Moving --\u0026gt; Crash Crash --\u0026gt; [*] ```  renders as\nstateDiagram [*] --\u0026gt; Still Still --\u0026gt; [*] Still --\u0026gt; Moving Moving --\u0026gt; Still Moving --\u0026gt; Crash Crash --\u0026gt; [*]  Todo lists You can even write your todo lists in Academic too:\n- [x] Write math example - [x] Write diagram example - [ ] Do something else  renders as\n Write math example Write diagram example Do something else  Tables Represent your data in tables:\n| First Header | Second Header | | ------------- | ------------- | | Content Cell | Content Cell | | Content Cell | Content Cell |  renders as\n   First Header Second Header     Content Cell Content Cell   Content Cell Content Cell    Callouts Academic supports a shortcode for callouts, also referred to as asides, hints, or alerts. By wrapping a paragraph in {{% callout note %}} ... {{% /callout %}}, it will render as an aside.\n{{% callout note %}} A Markdown aside is useful for displaying notices, hints, or definitions to your readers. {{% /callout %}}  renders as\n A Markdown aside is useful for displaying notices, hints, or definitions to your readers.   Spoilers Add a spoiler to a page to reveal text, such as an answer to a question, after a button is clicked.\n{{\u0026lt; spoiler text=\u0026quot;Click to view the spoiler\u0026quot; \u0026gt;}} You found me! {{\u0026lt; /spoiler \u0026gt;}}  renders as\nClick to view the spoiler You found me!\n Icons Academic enables you to use a wide range of icons from Font Awesome and Academicons in addition to emojis.\nHere are some examples using the icon shortcode to render icons:\n{{\u0026lt; icon name=\u0026quot;terminal\u0026quot; pack=\u0026quot;fas\u0026quot; \u0026gt;}} Terminal {{\u0026lt; icon name=\u0026quot;python\u0026quot; pack=\u0026quot;fab\u0026quot; \u0026gt;}} Python {{\u0026lt; icon name=\u0026quot;r-project\u0026quot; pack=\u0026quot;fab\u0026quot; \u0026gt;}} R  renders as\n  Terminal\n Python\n R\nDid you find this page helpful? Consider sharing it üôå ","date":1562889600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1562889600,"objectID":"07e02bccc368a192a0c76c44918396c3","permalink":"https://academic-demo.netlify.app/post/writing-technical-content/","publishdate":"2019-07-12T00:00:00Z","relpermalink":"/post/writing-technical-content/","section":"post","summary":"Academic is designed to give technical content creators a seamless experience. You can focus on the content and Academic handles the rest.\nHighlight your code snippets, take notes on math classes, and draw diagrams from textual representation.","tags":null,"title":"Writing technical content in Academic","type":"post"},{"authors":["Marta Bofill Roig"],"categories":[],"content":"from IPython.core.display import Image Image('https://www.python.org/static/community_logos/python-logo-master-v3-TM-flattened.png')     print(\u0026quot;Welcome to Academic!\u0026quot;)  Welcome to Academic!  Install Python and JupyterLab Install Anaconda which includes Python 3 and JupyterLab.\nAlternatively, install JupyterLab with pip3 install jupyterlab.\nCreate or upload a Jupyter notebook Run the following commands in your Terminal, substituting \u0026lt;MY-WEBSITE-FOLDER\u0026gt; and \u0026lt;SHORT-POST-TITLE\u0026gt; with the file path to your Academic website folder and a short title for your blog post (use hyphens instead of spaces), respectively:\nmkdir -p \u0026lt;MY-WEBSITE-FOLDER\u0026gt;/content/post/\u0026lt;SHORT-POST-TITLE\u0026gt;/ cd \u0026lt;MY-WEBSITE-FOLDER\u0026gt;/content/post/\u0026lt;SHORT-POST-TITLE\u0026gt;/ jupyter lab index.ipynb  The jupyter command above will launch the JupyterLab editor, allowing us to add Academic metadata and write the content.\nEdit your post metadata The first cell of your Jupter notebook will contain your post metadata (front matter).\nIn Jupter, choose Markdown as the type of the first cell and wrap your Academic metadata in three dashes, indicating that it is YAML front matter:\n--- title: My post's title date: 2019-09-01 # Put any other Academic metadata here... ---  Edit the metadata of your post, using the documentation as a guide to the available options.\nTo set a featured image, place an image named featured into your post\u0026rsquo;s folder.\nFor other tips, such as using math, see the guide on writing content with Academic.\nConvert notebook to Markdown jupyter nbconvert index.ipynb --to markdown --NbConvertApp.output_files_dir=.  Example This post was created with Jupyter. The orginal files can be found at https://github.com/gcushen/hugo-academic/tree/master/exampleSite/content/post/jupyter\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1567641600,"objectID":"6e929dc84ed3ef80467b02e64cd2ed64","permalink":"https://academic-demo.netlify.app/post/jupyter/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/post/jupyter/","section":"post","summary":"Learn how to blog in Academic using Jupyter notebooks","tags":[],"title":"Display Jupyter Notebooks with Academic","type":"post"},{"authors":[],"categories":[],"content":"Create slides in Markdown with Wowchemy Wowchemy | Documentation\n Features  Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides   Controls  Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export: E   Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026quot;blueberry\u0026quot; if porridge == \u0026quot;blueberry\u0026quot;: print(\u0026quot;Eating...\u0026quot;)   Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = ;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\n Fragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}}  Press Space to play!\nOne  Two  Three \n A fragment can accept two optional parameters:\n class: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears   Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}}  Press the S key to view the speaker notes!\n Only the speaker can read these notes Press S key to view    Themes  black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links    night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links   Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026quot;/media/boards.jpg\u0026quot; \u0026gt;}} {{\u0026lt; slide background-color=\u0026quot;#0000FF\u0026quot; \u0026gt;}} {{\u0026lt; slide class=\u0026quot;my-style\u0026quot; \u0026gt;}}   Custom CSS Example Let\u0026rsquo;s make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; }   Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"https://academic-demo.netlify.app/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using Wowchemy's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":["Marta Bofill Roig","Guadalupe G√≥mez Melis"],"categories":null,"content":"Abstract: Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint. As shown in this work, when using a composite binary endpoint to size a trial, one needs to specify the event rates and the effect sizes of the composite components as well as the correlation between them. In practice, the marginal parameters of the components can be obtained from previous studies or pilot trials, however, the correlation is often not previously reported and thus usually unknown. We first show that the sample size for composite binary endpoints is strongly dependent on the correlation and, second, that slight deviations in the prior information on the marginal parameters may result in underpowered trials for achieving the study objectives at a pre-specified significance level. We propose a general strategy for calculating the required sample size when the correlation is not specified, and accounting for uncertainty in the marginal parameter values. We present the web platform CompARE to characterize composite endpoints and to calculate the sample size just as we propose in this paper. We evaluate the performance of the proposal with a simulation study, and illustrate it by means of a real case study using CompARE.\n","date":1530576000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1530576000,"objectID":"f896575860c7f5c3f53051248b64104f","permalink":"https://academic-demo.netlify.app/publication/journal-article/bg_2018/","publishdate":"2018-07-03T00:00:00Z","relpermalink":"/publication/journal-article/bg_2018/","section":"publication","summary":"Abstract: Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint.","tags":[],"title":"A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components","type":"publication"},{"authors":["Marta Bofill Roig","Guadalupe G√≥mez Melis"],"categories":null,"content":"Abstract: The choice of a primary endpoint is an important issue when designing a clinical trial. It is common to use composite endpoints as a primary endpoint because it increases the number of observed events, captures more information and is expected to increase the power. However, combining events that have no similar clinical importance and have different treatment effects makes the interpretation of the results cumbersome and might reduce the power of the corresponding tests. G√≥mez and Lagakos proposed the ARE (asymptotic relative efficiency) method to choose between a composite or one of its components as primary endpoint comparing the efficacy of a treatment based on the times to each of these endpoints. The aim of this paper is to expand the ARE method to binary endpoints. We show that the ARE method depends on six parameters including the degree of association between components, event proportion, and effect of therapy given by the corresponding odds ratio of the single endpoints. A case study is presented to illustrate the methodology. We conclude with efficient guidelines for discerning which could be the best suited primary endpoint given anticipated parameters.\n","date":1507766400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1507766400,"objectID":"b3c0968788449f55c1d0e58da8245fc6","permalink":"https://academic-demo.netlify.app/publication/journal-article/bg_2017/","publishdate":"2017-10-12T00:00:00Z","relpermalink":"/publication/journal-article/bg_2017/","section":"publication","summary":"Abstract: The choice of a primary endpoint is an important issue when designing a clinical trial. It is common to use composite endpoints as a primary endpoint because it increases the number of observed events, captures more information and is expected to increase the power.","tags":[],"title":"Selection of composite binary endpoints in clinical trials","type":"publication"},{"authors":null,"categories":null,"content":"Adaptive Designs and Multiple Testing Procedures Working Group.\nJoint Working Group (Section) of the ROeS and the German Region of the IBS: https://www.biometrische-gesellschaft.de/arbeitsgruppen/adaptive-designs-multiple-testing-procedures.html\nThe annual workshop in 2024 took place in Ibiza from the 25th to 26th of April.\n  Website of the workshop https://admtp.github.io/ADMTP2024/ with photo gallery.\n  Twitter account at https://twitter.com/ADMTP_IBS\n  Press coverage at Diario de Ibiza and Nou Diari\n  ","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"123df49921882a77b91d1623167c055f","permalink":"https://academic-demo.netlify.app/project/admtp/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/admtp/","section":"project","summary":"Adaptive Designs and Multiple Testing Procedures Working Group","tags":["Research"],"title":"ADMTP","type":"project"},{"authors":null,"categories":null,"content":"CompARE is a set of software tools for the design of trials with composite endpoint. CompARE includes Shiny Apps and an R package.\nThe Shiny apps are split into two apps for time-to-event and binary endpoints, respectively. With its user-friendly interface, these Shiny apps allow to input the main parameters included in the trial -such as the treatment effect on the components of the composite endpoint, and its frequencies of occurrence- and helps provide power and sample size calculations among others.\nThe R package version includes the same features as the Shiny apps, plus others related to data simulation or multi-arm studies. You can also find the R-package version of CompARE in CRAN CompAREdesign.\n","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"511a66f43e83a00bdc7a23d5f4297cef","permalink":"https://academic-demo.netlify.app/project/compare/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/compare/","section":"project","summary":"Working group on the design of clinical trials with composite endpoints","tags":["Research"],"title":"CompARE","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"6b79863f37f72922a23768ebf3efa017","permalink":"https://academic-demo.netlify.app/project/eupearl/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/eupearl/","section":"project","summary":"EU-PEARL aims to create a tested and trusted framework for patient-centric integrated research platform trials","tags":["Research"],"title":"EU-PEARL","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"0a59ca4cee9c0c379dc126976c3e3702","permalink":"https://academic-demo.netlify.app/project/ewhorm/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/ewhorm/","section":"project","summary":"eWHORM Project to Eliminate Worm Infections in Sub-Saharan Africa. eWHORM  aims to develope and test more efficacious and safe treatment options that act across different helminth species","tags":["Research"],"title":"eWHORM","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"172593467360e1ec2852a837a6f8389a","permalink":"https://academic-demo.netlify.app/project/grbio/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/grbio/","section":"project","summary":"Research group with an expertise in Biostatistics and Bioinformatics","tags":["Research"],"title":"GRBIO","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"85e6a12f34dda272efbdbc77181fb297","permalink":"https://academic-demo.netlify.app/project/ncc/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/ncc/","section":"project","summary":"Working group on software for platform trials  using non-concurrent control data","tags":["Research"],"title":"NCC","type":"project"},{"authors":null,"categories":null,"content":"","date":-62135596800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":-62135596800,"objectID":"f26b5133c34eec1aa0a09390a36c2ade","permalink":"https://academic-demo.netlify.app/admin/config.yml","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/admin/config.yml","section":"","summary":"","tags":null,"title":"","type":"wowchemycms"}]